Follow-Up on Blood-Based Colorectal Cancer Screening Results Is Low

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 5, 2025.

via HealthDay

TUESDAY, Aug. 5, 2025 -- Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within six months, according to a study published online July 29 in Gastroenterology.

Timothy A. Zaki, M.D., from the University of California, Los Angeles (UCLA), and colleagues analyzed closed claims data to determine the FU-CY rate after an abnormal blood-based test result and identified predictors of FU-CY using national data. The analysis included 6,068 individuals who underwent a commercially available, blood-based colorectal cancer screening test (Shield, Guardant Health) with linked administrative data.

The researchers found that 7.4 percent of individuals had an abnormal result. Of the 228 individuals with at least six months of follow-up, 49 percent received an FU-CY within six months (mean time to FU-CY, 66.4 days). At any time, 128 individuals (56 percent) received an FU-CY (mean time to FU-CY, 98.3 days overall). Individuals with Medicare Advantage (adjusted odds ratio [aOR], 0.26) were less likely to undergo FU-CY within six months versus those with private insurance. FU-CY at six months was also associated with having fewer comorbidities (aOR, 0.90). Age, race/ethnicity, and U.S. census region were not significant predictors of FU-CY within six months.

"Blood-based colorectal cancer screening is promising, but it only works if individuals complete the follow-up colonoscopy," senior author Folasade May, M.D., Ph.D., also from UCLA, said in a statement. "More efforts are needed to help patients follow through to actually diagnose and treat the disease."

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-06 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords